Position in ACLX
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$43,401,960
New position
Shares Held
378,000
first reported quarter
Ownership
0.646%
of shares outstanding
% of Portfolio
2.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALPINE ASSOCIATES MANAGEMENT INC. holds $162,950,667 across 6 Biotechnology names. ACLX ranks #1 (26.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
This page
|
378,000 | $43,401,960 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
864,000 | $34,758,720 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
865,500 | $34,377,660 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,596,190 | $23,080,907 | |
| 5 | DAWN |
Day One Biopharmaceuticals, Inc.
|
925,000 | $19,832,000 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
142,250 | $7,499,420 |
All Filings in ACLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,401,960 | 378,000 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||